Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation
2011

Synthesis and Evaluation of α-Galactosyl Ceramide Analogues

publication Evidence: moderate

Author Information

Author(s): Veerapen Natacha, Reddington Faye, Salio Mariolina, Cerundolo Vincenzo, Besra Gurdyal S.

Primary Institution: University of Birmingham

Hypothesis

The length of the sphingosine chain in α-galactosyl ceramides influences the cytokine release profile.

Conclusion

The synthesized truncated analogues of α-GalCer were found to be less potent than α-GalCer and did not induce a Th2 skewing in human iNKT cells.

Supporting Evidence

  • The study synthesized three truncated analogues of α-GalCer with varying sphingosine chain lengths.
  • Biological evaluation showed that the longest chain induced the greatest cytokine response.
  • Human iNKT cells did not show a strong Th2 bias when stimulated with the new analogues.

Takeaway

Scientists made new versions of a molecule that helps the immune system and found that the length of a part of the molecule affects how it works.

Methodology

The study involved synthesizing analogues of α-GalCer with varying sphingosine chain lengths and evaluating their biological activity using human iNKT cells.

Limitations

The analogues were generally less potent than α-GalCer and did not show the expected Th2 skewing in human cells.

Digital Object Identifier (DOI)

10.1016/j.bmc.2010.11.032

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication